Доктор Михаэла Гольдштейн

Doctor Michaella Goldstein

Email to Doctor Goldstein


Ophthalmologist with over 25 years of work experience, Head of Retinal Disease Department of the Ichilov Medical Center. Was awarded with the title of the best physician in this medical center.


  • Provides early detection of age-related retinal detachment.
  • Offers monitoring and treatment for diabetic retinopathy and retinal vascular disorders.
  • Performs a wide range of retinal studies including optical coherence tomography and fluorescein angiography.
  • Uses advanced laser technologies for retinal disease treatment.

Diseases Treated by the Physician:

  • Chorioretinitis
  • Diabetic retinopathy
  • Glaucoma
  • Hypertensive retinopathy
  • Myopia
  • Retinal degeneration
  • Retinal tear
  • Retinal angiopathy
  • Retinal detachment
  • Retinal hemorrhage



медцентре Шиба

Tel Aviv State University (Israel), lecturer at Ophthalmology Department

Head of the Department of Retina and Vitreous Diseases, Ichilov-Sourasky Medical Center

Private practice at the Top Ichilov Clinic

Deputy Head of Ophthalmology Department, Ichilov-Sourasky Medical Center

Senior physician of Ophthalmology Department, Ichilov Medical Center

Physician of Ophthalmology Department, Ichilov-Sourasky Medical Center

Ophthalmologist in the military base for recruitment and military training, Israel Defense Forces

Лондонский Офтальмологический госпиталь

Moorfields Eye Hospital in London (England), specialization in retinal diseases

Ichilov-Sourasky Medical Center, specialization in ophthalmology

Beilinson Clinic (Israel), specialization in ophthalmology

Tel Aviv State University, specialization in ophthalmology

Tel Aviv State University, Faculty of Medicine

Association for Research in Vision and Ophthalmology (ARVO)

Израильская ассоциация офтальмологов лого

Israel Ophthalmology Society

Израильская ассоциация офтальмологов лого

Israel Society for Vision and Eye Research

Doctor Goldstein is an experienced Israeli ophthalmologist, expert in treatment of retinal diseases including diabetic retinopathy.

“Age-related macular degeneration is a condition that progresses throughout life. As a rule, it is detected in people over 50. Many patients pay no attention to the vision loss until they are 60 or 70. In 10-15% of cases, we detect the so-called wet macular degeneration. Without treatment, this condition leads to persistent vision loss.

About 10 years ago, we developed a new treatment method. This method implies injecting medicine directly into the eye. Historically, patients were recommended conventional monthly injections.

Today, we can use an advanced technology called optical coherence tomography, or OCT. It helps determine whether the medicine is effective. If required, we can change the dosage and personalize the therapy because some patients simply do not need monthly intraocular injections. Therefore, OCT and inexpensive injected medications helps us develop personalized treatment plans for our patients.”

Was celebrated by the independent “Dun & Bradstreet Israel” audit company as one of the leading specialists in her field and included into the rating of 194 best ophthalmologists, cardiologists and surgeons of the country.

Skip to content